Lok Sabha Question No. 3531 (UNSTARRED), answered on 2017-08-08
Subject: Upgradation of NIPER, Chandigarh
Ministry: CHEMICALS AND FERTILIZERS
Asked by: ANJU BALA

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEAUTICALS

LOK SABHA UNSTARRED QUESTION NO. 3531 TO BE ANSWERED ON THE 8 TH  August 2017

## Upgradation of NIPER, Chandigarh

3531. SHRIMATI ANJU BALA:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) whether the Government has received suggestions regarding improvement/upgradation of the National  Institute  of  Pharmaceutical  Education  and  Research  (NIPER),  Chandigarh  from  the Parliamentary Delegation which visited the institute recently in June 2017 and if so, the details thereof;
- (b)  the number of patents granted to NIPER during the last decade (2007-2017) and its major achievements during the said period;
- (c)  whether the Government is planning to upgrade the very old machinery installed in NIPER which is now in redundant condition and if so, the details thereof; and
- (d)  the  steps  taken/being  taken  and  funds  allocated  by  the  Government  for  development  of NIPER as Model Pharmaceutical Research Organisation during the last three years?

## ANSWER

## MINISTER  OF  STATE  IN  THE  MINISTRY  OF  ROAD  TRANSPORT  AND  HIGHWAYS; MINISTRY  OF  SHIPPING  AND  MINISTRY  OF  CHEMICALS  AND  FERTILIZERS  (SHRI MANSUKH L. MANDAVIYA)

- (a)  No  madam.  The  Parliamentary  Standing  Committee  on  Chemicals  &  Fertilizers  has undertaken  a  study  visit  to  NIPER,  Mohali  in  June,  2017  in  connection  with  examination  of various  subjects  selected  by  the  Committee.  Subsequently,  an  Oral  Evidence  before  the Standing Committee on the subject ' Promotion and Co-ordination of Basic Applied Research in areas  related  to  Pharmaceutical  Sector ' with  a  special  reference  to  budgetary  allocation  to NIPERs for R&D activities was held on 30.06.2017 at Parliament House, New Delhi.  However, recommendations/suggestions of the Committee on the subject have not been received as yet.
- (b) NIPER, Mohali has filed 112 Patents, out of which 40 Patents have been granted during the period 2007-2017. The major achievements of the Institute during the period are indicated in the Annexure.
- (c) Standing Finance Committee (SFC) of the Department  in its meeting held on 25.8.2015 has approved an amount of  Rs. 249.455 crore  under the teaching and infrastructure components for NIPER, Mohali. An amount of Rs. 9.79 crore was released to NIPER, Mohali during Financial Year 2015-16 for up-gradation.
- (d) Grants of Rs. 88.05 crore have been released to NIPER, Mohali during the last three years (2014-15 to 2016-17) under plan and non-plan heads.
1. Institutional recognition :
- 1.1 Ranked second best pharmacy Institute in the country in the National Institutional Ranking Framework ( NIRF ), 2017 of Ministry of Human Resource Development, Government of India.
- 1.2 Received Thomson Reuters Innovation Award, 2011 (Govt. sector).
2. Research output :
- 2.1 Publications: >2000
- 2.2 Patents granted: 41 (including international)
- 2.3 National and international awards to faculty members, including Shanti Swaroop Bhatnagar  Award,  National  Bioscience  Award,  Ranbaxy  Research  Award,  J.  C.  Bose Fellowship, etc.
- 2.4 National  and  international  fellowships  of  academic  societies,  including  Indian  National Science  Academy,  Indian  Pharmacological  Society,  National  Academy  of  Sciences, American Association of Pharmaceutical Sciences, etc.
- 2.5 National and international awards to students, including Sun Pharma/ Ranbaxy research scholar  award,  Commonwealth  fellowship,  DAAD  fellowship,  Nehru-Fulbright  fellowship, Lindau Nobel Laureates ' Meet, etc. In addition, students were awarded by many national and  international  agencies  as  well  as  international  pharmaceutical  companies  to  attend and present their research work in seminars/conferences (>100 during the period).
3. Support to industry :
- 3.1 Establishment of:
- (i)   National Toxicology Centre, the first GLP-certified set-up for toxicology testing in the government sector;
- (ii)  Small  and  Medium  Pharmaceutical  Industry  Centre,  which  makes  available  the Institute ' s facilities to SMEs at half the cost and also provides didactic and hands-on training in regulatory and analytical training for these entities.
- 3.2  Technologies transferred: Three (Four are in the pipeline)
- 3.3  Seven  MoUs signed with industries to promote industry-academia partnership, including those with Sun Pharma, Biocon, Wockhardt, Panacea Biotec, etc.
- 3.4 Consultancies provided to the industry
4. Placement of students :
- 4.1 Students placed in top pharma companies (domestic and multi-nationals).

*****

## Annexure